ATHE logo

ATHE Stock Overview

Profile

Full Name:

Alterity Therapeutics Limited

Sector:

Healthcare

Industry:

Biotechnology

Country:

Australia

IPO:

September 29, 2003

Indexes:

Not included

Website:

http://alteritytherapeutics.com

Description:

Alterity Therapeutics Limited (ATHE) is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases. They aim to improve the lives of patients with conditions like Alzheimer's and Parkinson's by advancing new therapies that target the underlying causes of these disorders.

Key Details

Price

$3.76

Market Cap

$40.18 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$2.05(+11.11% YoY)

PE Ratio

-

Annual ROE

-135.94%

Annual Debt To Equity

0.01

Beta

1.51

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Jul 22, 2022

Recent annual earnings:

Jul 22, 2022
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 9, 2023

Analyst ratings

Recent major analysts updates

Jan 30, 25 Maxim Group
Buy
Dec 12, 24 Maxim Group
Buy
Mar 7, 24 Benchmark
Speculative Buy
Jun 5, 23 Ladenburg Thalmann
Buy
Aug 3, 22 Ladenburg Thalmann
Buy
Jun 23, 22 Goldman Sachs
Neutral
Aug 20, 21 Benchmark
Speculative Buy

Screeners with ATHE included

Growing Shares Outstanding
Stocks with high beta
Best performing stocks last 3 months
Stocks above SMA 50
Healthcare sector
All stocks
Biotechnology industry
Small cap stocks
Stocks above SMA 200
NASDAQ earnings calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$3.76
ATHE price is $3.76

Price All-time High

$739.80
ATHE price is currently -99.49% below its historical high of $739.80

Price Analysts Target

-
ATHE price consensus analysts' forecast is unknown

Price Today Change

0%
ATHE {parameterFullLabel} is unchanged today

Price YTD Change

+15.69%
ATHE price is up +15.69% since January 1st

Price 3-Year Change

-55.76%
ATHE price is down -55.76% over the past 3 years

Market cap

Market Cap

$40.18 M
ATHE market capitalization is $40.18 million

Market Cap 3-Year Change

+17.83%
ATHE market capitalization is up +17.83% over the past 3 years

Market Cap All-time High

$513.50 M
ATHE market capitalization is currently -92.18% below its historical high of $513.50 million

Market Cap Sector Rank

33.03%
ATHE market capitalization is higher than 33.03% of companies in Healthcare sector

Technical

Beta

1.51
ATHE beta is 1.51

200-day SMA

$2.05
ATHE price is currently +83.74% above its 200-day simple moving average

14-day RSI

48.21
ATHE 14-day relative strength index is 48.21

30-day Relative Volume

0.04
ATHE 30-day relative volume is 0.04

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
ATHE annual revenue value is unknown

Annual Revenue Analysts Estimate

$2.72 M
ATHE annual revenue is currently equal to the consensus analysts' forecast

Annual Revenue 1-Year Change

-
ATHE annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
ATHE annual revenue is unknown

Profit

Annual Gross Profit

-
ATHE annual gross profit value is unknown

Annual Gross Margin

-
ATHE annual gross profit margin value is unknown

Annual Operating Profit

-$12.71 M
ATHE annual operating income is -$12.71 million

Annual Operating Margin

-
ATHE annual operating profit margin value is unknown

Annual Net Income

-$12.54 M
ATHE annual net profit is -$12.54 million

Annual Net Margin

-
ATHE annual net profit margin value is unknown

EPS

Annual EPS

-$2.05
ATHE annual earnings per share is -$2.05

Annual EPS Analysts Estimate

-$0.77
ATHE annual earnings per share is currently +165.33% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+11.11%
ATHE annual earnings per share is up +11.11% year-on-year

Annual EPS Sector Rank

41.56%
ATHE annual earnings per share is higher than 41.56% of companies in Healthcare sector

ROA & ROE

Annual ROA

-97.57%
ATHE annual return on assets is -97.57%

Annual ROE

-135.94%
ATHE annual return on equity is -135.94%

EBIT & EBITDA

Annual EBIT

-$12.71 M
ATHE annual earnings before interest & taxes is -$12.71 million

Annual EBITDA

-$12.62 M
ATHE annual EBITDA is -$12.62 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
ATHE price to earnings ratio value is unknown

PE Ratio Sector Rank

-
ATHE price to earnings ratio is unknown

PB Ratio

PB Ratio

4.36
ATHE price to book ratio is 4.36

PB Ratio Sector Rank

78.43%
ATHE price to book ratio is higher than 78.43% of companies in Healthcare sector

PS Ratio

PS Ratio

-
ATHE price to sales ratio value is unknown

PS Ratio Sector Rank

-
ATHE price to sales ratio is unknown

Enterprise value

Enterprise Value

$31.84 M
ATHE enterprise value is $31.84 million

Enterprise Value Sector Rank

34.42%
ATHE enterprise value is higher than 34.42% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
ATHE EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
ATHE EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

3.54
ATHE annual current ratio is 3.54

Annual Quick Ratio

-
ATHE annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.01
ATHE annual debt to equity ratio is 0.01

Annual Interest Coverage Ratio

-
ATHE annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ATHE piotroski f-score value is unknown

Altman Z-Score

-
ATHE altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$12.85 M
ATHE annual total assets is $12.85 million

Annual Non Current Assets

$124.90 K
ATHE annual long term assets is $124.90 thousand

Annual Current Assets

$12.72 M
ATHE annual total current assets is $12.72 million

Annual Cash & Cash Equivalents

$8.45 M
ATHE annual cash & cash equivalents is $8.45 million

Equity

Annual Book Value

$9.22 M
ATHE annual book value is $9.22 million

Annual Working Capital

$9.13 M
ATHE annual working capital is $9.13 million

Liabilities

Annual Total Liabilities

$3.63 M
ATHE annual total liabilities is $3.63 million

Annual Total Long Term Liabilities

$34.70 K
ATHE annual total long term liabilities is $34.70 thousand

Annual Current Liabilities

$3.59 M
ATHE annual total current liabilities is $3.59 million

Annual Accounts Payable

$388.40 K
ATHE annual accounts payable is $388.40 thousand

Debt

Annual Total Debt

$106.30 K
ATHE annual total debt is $106.30 thousand

Annual Total Debt 1-Year Change

-23.64%
ATHE annual total debt is down -23.64% year-on-year

Annual Long Term Debt

$34.70 K
ATHE annual long term debt is $34.70 thousand

Annual Short Term Debt

$71.60 K
ATHE annual short term debt is $71.60 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$12.71 M
ATHE annual total expenses is $12.71 million

Annual Operating Expenses

$12.71 M
ATHE annual total operating expenses is $12.71 million

Annual Cost Of Goods Sold

-
ATHE annual cost of goods sold value is unknown

Annual SGA

$3.03 M
ATHE annual SGA is $3.03 million

Annual D&A

$96.70 K
ATHE annual depreciation & amortization is $96.70 thousand

Annual Interest Expense

-
ATHE annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$8.26 M
ATHE annual cash flow from operations is -$8.26 million

Annual CFO 1-Year Change

+38.7%
ATHE annual cash flow from operations is up +38.7% year-on-year

Annual CFI

-$3800.00
ATHE annual cash flow from investing activities is -$3800.00

Annual CFI 1-Year Change

+84.49%
ATHE annual cash flow from investing activities is up +84.49% year-on-year

Annual CFF

$6.04 M
ATHE annual cash flow from financing activities is $6.04 million

Annual CFF 1-Year Change

+7118.64%
ATHE annual cash flow from financing activities is up +7118.64% year-on-year

Free CashFlow

Annual FCF

-$8.27 M
ATHE annual free cash flow is -$8.27 million

Annual FCF 1-Year Change

+38.69%
ATHE annual free cash flow is up +38.69% year-on-year

CAPEX

Annual CAPEX

-
ATHE annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
ATHE annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

CLGN logo
CollPlant Biotechnologies (CLGN)
Grace Therapeutics (GRCE)
FGEN logo
FibroGen (FGEN)
XLO logo
Xilio Therapeutics (XLO)
SHLT logo
SHL Telemedicine (SHLT)
RAPT logo
RAPT Therapeutics (RAPT)
LSB logo
LakeShore Biopharma Co Ltd (LSB)
SCYX logo
SCYNEXIS (SCYX)
OVID logo
Ovid Therapeutics (OVID)

FAQ

  • What is the ticker symbol for Alterity Therapeutics Limited?
  • Does Alterity Therapeutics Limited pay dividends?
  • What sector is Alterity Therapeutics Limited in?
  • What industry is Alterity Therapeutics Limited in?
  • What country is Alterity Therapeutics Limited based in?
  • When did Alterity Therapeutics Limited go public?
  • Is Alterity Therapeutics Limited in the S&P 500?
  • Is Alterity Therapeutics Limited in the NASDAQ 100?
  • Is Alterity Therapeutics Limited in the Dow Jones?
  • When was Alterity Therapeutics Limited's last earnings report?
  • When does Alterity Therapeutics Limited report earnings?

What is the ticker symbol for Alterity Therapeutics Limited?

The ticker symbol for Alterity Therapeutics Limited is NASDAQ:ATHE

Does Alterity Therapeutics Limited pay dividends?

No, Alterity Therapeutics Limited does not pay dividends

What sector is Alterity Therapeutics Limited in?

Alterity Therapeutics Limited is in the Healthcare sector

What industry is Alterity Therapeutics Limited in?

Alterity Therapeutics Limited is in the Biotechnology industry

What country is Alterity Therapeutics Limited based in?

Alterity Therapeutics Limited is headquartered in Australia

When did Alterity Therapeutics Limited go public?

Alterity Therapeutics Limited's initial public offering (IPO) was on September 29, 2003

Is Alterity Therapeutics Limited in the S&P 500?

No, Alterity Therapeutics Limited is not included in the S&P 500 index

Is Alterity Therapeutics Limited in the NASDAQ 100?

No, Alterity Therapeutics Limited is not included in the NASDAQ 100 index

Is Alterity Therapeutics Limited in the Dow Jones?

No, Alterity Therapeutics Limited is not included in the Dow Jones index

When was Alterity Therapeutics Limited's last earnings report?

Alterity Therapeutics Limited's most recent earnings report was on Jul 22, 2022

When does Alterity Therapeutics Limited report earnings?

The date for Alterity Therapeutics Limited's next earnings report has not been announced yet